Subversion of drug testing programs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, May 17, 2005.
| Corporate Authors: | United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, ProQuest (Firm) |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Washington :
U.S. G.P.O. :
2005.
|
| Series: | U.S. Congressional Hearings.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Similar Items
Subversion of drug testing programs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, May 17, 2005.
Published: (2005)
Published: (2005)
Drug tests : products to defraud drug use screening tests are widely available : testimony before the Chairman, Subcommittee on Oversight and Investigations, Committeee on Energy and Commerce, House of Representatives /
by: Cramer, Robert J.
Published: (2005)
by: Cramer, Robert J.
Published: (2005)
Penalties for illegal activities in the approval of drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, on H.R. 4810 ... June 28, 1990.
Published: (1990)
Published: (1990)
Ketek clinical study fraud : what did Aventis know? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, February 12, 2008.
Published: (2008)
Published: (2008)
Ketek clinical study fraud : what did Aventis know? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, February 12, 2008.
Published: (2008)
Published: (2008)
An inquiry into the ImClone cancer-drug story : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, June 13 and October 10, 2002.
Published: (2002)
Published: (2002)
Magnitude, impact, and military response to Harrier jet and cruise missile testing improprieties by the Northrop Corporation : hearings before the Legislation and National Security Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred First Congress, second session, September 25; October 11 and 12, 1990.
Published: (1991)
Published: (1991)
Drug testing : undercover tests reveal significant vulnerabilities in DOT's drug testing program : testimony before the Subcommittee on Highways and Transit, Committee on Transportation and Infrastruture, House of Representatives /
by: Kutz, Gregory D.
Published: (2007)
by: Kutz, Gregory D.
Published: (2007)
FDA, Merck, and Vioxx : putting patient safety first? : hearing before the Committee on Finance, United States Senate, One Hundred Eighth Congress, second session, November 18, 2004.
Published: (2005)
Published: (2005)
Drug control : status of U.S. international counternarcotics activities : statement for the record by Benjamin F. Nelson, Director, International Relations and Trade Issues, National Security and International Affairs Division, before the Subcommittee on National Security, International Affairs, and Criminal Justice, Committee on Government Reform and Oversight, House of Representatives /
by: Nelson, Benjamin F.
Published: (1998)
by: Nelson, Benjamin F.
Published: (1998)
Online pharmacies and the problem of Internet drug abuse : hearing before the Subcommittee on Crime, Terrorism, and Homeland Security of the Committee on the Judiciary, House of Representatives, One Hundred Tenth Congress, second session, June 24, 2008.
Published: (2009)
Published: (2009)
Online pharmacies and the problem of Internet drug abuse : hearing before the Subcommittee on Crime, Terrorism, and Homeland Security of the Committee on the Judiciary, House of Representatives, One Hundred Tenth Congress, second session, June 24, 2008.
Published: (2009)
Published: (2009)
Drug pricing investigation : majority staff report /
Published: (2021)
Published: (2021)
Drug testing /
by: Fay, John, 1934-
Published: (1991)
by: Fay, John, 1934-
Published: (1991)
On-site drug testing /
Published: (2002)
Published: (2002)
Safety of imported pharmaceuticals : strengthening efforts to combat the sales of controlled substances over the Internet : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, December 13, 2005.
Published: (2005)
Published: (2005)
Drug pricing investigation: AbbVie : Humira and Imbruvica : staff report /
Published: (2021)
Published: (2021)
Workplace drug testing /
Published: (2011)
Published: (2011)
Safety testing of new drugs : laboratory predictions and clinical performance /
Published: (1984)
Published: (1984)
Drug testing in the workplace /
Published: (1989)
Published: (1989)
Workplace drug testing /
Published: (2008)
Published: (2008)
Medication and performance-enhancing drugs in horse racing : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Twelfth Congress, second session, July 12, 2012.
Published: (2012)
Published: (2012)
Medication and performance-enhancing drugs in horse racing : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Twelfth Congress, second session, July 12, 2012.
Published: (2012)
Published: (2012)
Drug testing in schools : an effective deterrent? : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, second session, May 30, 2000.
Published: (2001)
Published: (2001)
Drug testing /
by: Wish, Eric D.
Published: (1988)
by: Wish, Eric D.
Published: (1988)
Falsification of drug testing results : hearing before the Subcommittee on Transportation, Tourism, and Hazardous Materials of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, first session, June 16, 1987.
Published: (1988)
Published: (1988)
Short-supply prescription drugs : shining a light on the gray market : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Twelfth Congress, second session, July 25, 2012.
Published: (2013)
Published: (2013)
Workplace drug testing /
Published: (2008)
Published: (2008)
An inquiry into the ImClone cancer-drug story : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, June 13 and October 10, 2002.
Published: (2002)
Published: (2002)
FDA's generic drug enforcement and approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, March 7 and June 5, 1991.
Published: (1992)
Published: (1992)
Cutting edge issues in drug testing and drug treatment : hearing before the Subcommittee on National Security, International Affairs, and Criminal Justice of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, June 5, 1998.
Published: (1999)
Published: (1999)
Analytical aspects of drug testing /
Published: (1989)
Published: (1989)
Drug testing : the experience of the transportation industry /
by: McCallion, Gail
Published: (1989)
by: McCallion, Gail
Published: (1989)
USACE drug testing procedures for the Army's drug-free federal workplace (DFW) civilian drug testing program.
Published: (2001)
Published: (2001)
Counterfeit drugs : fighting illegal supply chains : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, February 27, 2014.
Published: (2015)
Published: (2015)
Drug pricing investigation: lost savings : how prohibiting Medicare negotiation has cost taxpayers : staff report /
Published: (2021)
Published: (2021)